Z4D.SI stock down 43.64% intraday on 30 Mar 2026: watch liquidity and valuation risks
Medi Lifestyle Limited (Z4D.SI stock) plunged 43.64% intraday to S$0.03 on 30 Mar 2026 on the Singapore Exchange (SES). The move came with a surge in trading volume to 35,700,400 shares versus an average of 114,391, signalling forced selling or position unwinds. Intraday range showed a low of S$0.03 and a high of S$0.04, with the previous close at S$0.06. For traders focused on top losers, the drop highlights immediate liquidity, valuation and short-term technical risks for Z4D.SI stock on the SES in SGD.
Intraday price action and volume for Z4D.SI stock
Today Z4D.SI stock fell from an open of S$0.04 to a session low of S$0.03, a -43.64% move versus the previous close of S$0.06. Volume exploded to 35,700,400 shares, a relative volume of 209.56, compared with the 50‑day average price of S$0.01 and 200‑day average of S$0.01. The combination of steep price decline and very high volume points to outsized selling interest that traders should monitor for follow-through or short-covering spikes.
Advertisement
Drivers behind the sell-off and Z4D.SI stock news
There is no single public announcement today from Medi Lifestyle, but weakness follows a history of volatile small‑cap trading and negative earnings: EPS is -0.01 and trailing P/E stands at -4.20. Market participants cite thin free float and recent retail swings in the healthcare small‑cap cohort as catalysts. For company details, see the corporate site and profile for background Medi Lifestyle website and company image profile.
Fundamentals and valuation snapshot for Z4D.SI stock
Medi Lifestyle reports a market cap of S$7,140,000 and shares outstanding of 170,000,000. Key ratios show weak liquidity with current ratio 0.52 and negative book value per share -0.01, while price‑to‑sales is 4.13. Revenue per share is 0.03 and net income per share is -0.03, reflecting slim scale and losses. These metrics explain the high implied risk and why analyst consensus reads conservatively.
Technical picture and trading signals on SES for Z4D.SI stock
Short-term indicators show an RSI near 61.00 and ADX 35.32, suggesting a strong intraday trend. Bollinger bands are wide with upper S$0.06 and middle S$0.02, supporting high volatility. On-chain momentum reads a 1‑day ROC of 250.00%, reflecting recent large percentage swings. Traders should note the extreme volume and potential bid‑ask gaps at these sub‑cent prices on the SES in SGD.
Meyka AI grade and model forecast for Z4D.SI stock
Meyka AI rates Z4D.SI with a score out of 100: 66.42 | Grade B | Suggestion: HOLD. This grade factors S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Company rating data (27 Mar 2026) shows a corporate rating C with a Sell recommendation from consensus analytics. Meyka AI’s forecast model projects monthly S$0.01, yearly S$0.02, and three‑year S$0.03. Compared with today’s price of S$0.03, the one‑year model implies about -34.01% downside versus current levels. Forecasts are model‑based projections and not guarantees.
Risks, sector context and opportunities for Z4D.SI stock
Z4D.SI stock sits in the Healthcare sector where peers have average P/E near 21.23 and healthier margins. Main risks are low liquidity, negative operating cash flow per share -0.02, and volatile trading that can amplify losses. Opportunities include recovery in postpartum services demand and commodity trading recovery; however any thesis must clear weak current ratio and negative equity per share before position sizing.
Final Thoughts
Medi Lifestyle (Z4D.SI stock) is a top intraday loser on 30 Mar 2026 after a 43.64% fall to S$0.03 on extraordinary volume of 35,700,400 shares. Short‑term risk is elevated due to thin liquidity, negative EPS -0.01, and a current ratio of 0.52. Meyka AI’s forecast model projects a one‑year price of S$0.02, implying approximately -34.01% from today’s level; this projection highlights downside in a base model scenario. Our price targets for risk management: a conservative recovery target of S$0.06 (year high) and a downside buffer near the year low S$0.01. For active traders, watch order books and stop levels; for longer‑term holders, require operational improvement or clearer cash flow turnaround before adding exposure. This analysis is produced with Meyka AI as an AI‑powered market analysis platform; forecasts and grades are model outputs and not investment advice.
Advertisement
FAQs
Why did Z4D.SI stock drop so sharply intraday?
Z4D.SI stock fell on 30 Mar 2026 amid heavy selling and a volume spike to 35,700,400 shares. Contributing factors are thin liquidity, negative EPS -0.01, and sentiment swings in small‑cap healthcare names. No single public corporate announcement explained the sell‑off.
What are the key valuation metrics for Z4D.SI stock?
Key metrics for Z4D.SI stock: market cap S$7,140,000, P/E -4.20, price‑to‑sales 4.13, book value per share -0.01, and current ratio 0.52. These signal small scale and elevated balance sheet risk.
What does Meyka AI forecast for Z4D.SI stock?
Meyka AI’s forecast model projects monthly S$0.01 and yearly S$0.02 for Z4D.SI stock. Compared with the current price S$0.03, the one‑year model shows about -34.01% implied downside. Forecasts are model‑based and not guarantees.
How should traders manage risk on Z4D.SI stock?
Manage risk by limiting position size, monitoring order book depth on the SES in SGD, and using tight stop losses due to high intraday volatility. Consider waiting for volume normalisation and clearer cash flow improvement before adding exposure to Z4D.SI stock.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Advertisement
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)